Smith G D
Departments of Obstetrics & Gynecology, Physiology and Urology, Reproductive Sciences Program, University of Michigan, 1301 East Catherine, Ann Arbor, MI 48109, USA.
Curr Womens Health Rep. 2001 Oct;1(2):143-51.
In vitro maturation (IVM) of human oocytes is an emerging assisted reproductive technology with great promise. To be successful, this process must entail both nuclear and cytoplasmic maturation. Endogenous regulation of oocyte maturation is a complex sequence of events regulated by endocrine parameters, oocyte/follicular cross-talk, and intra-oocyte kinase/phosphatase interactions. Although nuclear maturation during human oocyte IVM progresses normally, cytoplasmic maturation is significantly lacking, as exemplified by poor embryonic developmental competence and pregnancy rates. Advances made in immature oocyte isolation and oocyte and embryo culture conditions have increased the clinical feasibility of IVM. However, in order to achieve acceptable birth rates, future studies should focus on characterization and regulation of oocyte cytoplasmic maturation, and how oocyte-derived factors influence zygotic genome activation and embryonic developmental competence.
人类卵母细胞的体外成熟(IVM)是一项极具前景的新兴辅助生殖技术。要取得成功,这一过程必须同时实现核成熟和胞质成熟。卵母细胞成熟的内源性调节是由内分泌参数、卵母细胞/卵泡相互作用以及卵母细胞内激酶/磷酸酶相互作用所调控的一系列复杂事件。尽管人类卵母细胞IVM过程中的核成熟进展正常,但胞质成熟却明显不足,表现为胚胎发育能力差和妊娠率低。未成熟卵母细胞分离以及卵母细胞和胚胎培养条件方面的进展提高了IVM的临床可行性。然而,为了实现可接受的出生率,未来的研究应侧重于卵母细胞胞质成熟的特征和调节,以及卵母细胞衍生因子如何影响合子基因组激活和胚胎发育能力。